Inactive Instrument

diaDexus, Inc. Share Price OTC Bulletin Board

Pharmaceuticals

End-of-day quote OTC Bulletin Board
- ^USD	-

17/21/17	Diadexus, Inc. Went Out of Business	CI
08/18/08	Motion for Asset Sale Approved for Diadexus, Inc.	CI

Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.

Employees

Sector

Pharmaceuticals

More about the company

Market Cap	49.2T 42.3T 39.8T 36.32T 67.78T 46.64L 68.13T 5L 2L 23.84L 2L 2L 75.87L	P/E 2014	-3.26x	P/E 2015	-1.14x
Enterprise Value	52.9L 45.49L 42.79L 39.05L 72.88L 50Cr 73.25L 5.07Cr 1.96Cr 26Cr 1.99Cr 1.94Cr 82Cr	EV / Sales 2014	1.05x	EV / Sales 2015	0.77x
Free-Float	100%	Yield 2014 *	-	Yield 2015	-

17/21/17	Diadexus, Inc. Went Out of Business	CI
08/18/08	Motion for Asset Sale Approved for Diadexus, Inc.	CI
09/18/09	Motion for Asset Sale Filed by Diadexus, Inc.	CI
01/16/01	Diazyme Laboratories, Inc. completed the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
29/16/29	Motion for Asset Sale Approved for Diadexus, Inc.	CI
29/16/29	General Atomics Corp. entered into purchase agreement to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $4.8 million.	CI
20/16/20	Cleveland HeartLab, Inc. cancelled the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
07/16/07	Motion for Asset Sale Filed by Diadexus, Inc.	CI
07/16/07	Cleveland HeartLab, Inc. agreed to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $7 million.	CI
13/16/13	Diadexus, Inc. Filed for Bankruptcy	CI
10/16/10	Diadexus, Inc. Announces Resignation of Leone Patterson as Chief Financial Office	CI
23/16/23	Diadexus, Sonic Healthcare USA Sign National Agreement for PLAC Activity Test	CI
30/16/30	Diadexus, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2016	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAREPTA THERAPEUTICS, INC.	-6.93%	-1.83%	+18.98%	-82.54%	237.66Cr
ULTRAGENYX PHARMACEUTICAL INC.	-2.75%	-42.35%	-52.78%	-63.84%	150.38Cr
BIONOTE, INC.	-2.09%	-1.89%	-17.46%	-8.41%	36Cr
DK LIFE SCIENCE CO., LTD.	-0.88%	-2.18%	-48.03%	-	5.38Cr
Average	-3.16%	-8.93%	-24.82%	-51.60%	107.31Cr
Weighted average by Cap.	-4.99%	-9.92%	-10.04%	-69.64%

	2014	2015
Net sales	2.61Cr 2.25Cr 2.11Cr 1.93Cr 3.6Cr 247.55Cr 3.62Cr 25Cr 9.68Cr 126.53Cr 9.81Cr 9.59Cr 402.65Cr	1.79Cr 1.54Cr 1.45Cr 1.32Cr 2.46Cr 169.55Cr 2.48Cr 17Cr 6.63Cr 87Cr 6.72Cr 6.57Cr 275.77Cr
Net income	-84.67L -72.8L -68.49L -62.5L -1.17Cr -80Cr -1.17Cr -8.11Cr -3.14Cr -41Cr -3.18Cr -3.11Cr -130.56Cr	-71.66L -61.61L -57.97L -52.9L -98.72L -68Cr -99.23L -6.87Cr -2.66Cr -35Cr -2.69Cr -2.63Cr -110.5Cr
Net Debt	-2L -2L -2L -1L -3L -1.88Cr -3L -18.98L -7L -95.94L -7L -7L -3.05Cr	52.41L 45.06L 42.39L 38.69L 72.2L 50Cr 72.57L 5.02Cr 1.94Cr 25Cr 1.97Cr 1.93Cr 81Cr

diaDexus, Inc. Share Price OTC Bulletin Board

Stocks

Pharmaceuticals

Valuation : diaDexus, Inc.

Latest news : diaDexus, Inc.

Diagnostic & Testing Substances Manufacturers

Financials

Company Profile